Amyloid is defined as insoluble, extracellular, proteinous aggregates formed by misfolding of proteins or peptides which are normally soluble. In the human body, amyloid is toxic and can cause cell death. Therefore, the presence of amyloid is linked with several diseases, including Alzheimer’s disease (AD), spongiform encephalopathies and type II diabetes, which are also referred as amyloidosis. AD is one of the most well-known amyloidoses. In AD, the amyloid aggregates appear predominantly in the patients’ brain, composed by a certain group of peptides known as amyloid beta (Aβ) peptides. Current clinical diagnoses of AD are primarily based on cognitive symptoms. However, it is often too late for intervention when the symptoms are detectab...
Amyloidosis are diseases characterised by self-agregation of misfolded proteins in fibrillary forms,...
Alzheimers disease (AD) is a common neurodegenerative disease that brings about enormous economic pr...
International audienceMagnetic nanoparticles (MNPs) have great potential in biomedical and clinical ...
Amyloid is defined as insoluble, extracellular, proteinous aggregates formed by misfolding of protei...
International audienceGadolinium-based nanoparticles were functionalized with either the Pittsburgh ...
International audienceAmyloid-β (Aβ) fibrillization is described as a central event in the pathogene...
Alzheimer’s disease (AD) is the most common neurodegenerative disease characterised by the developme...
One of the pathological hallmarks of Alzheimer’s disease (AD) is the abnormal aggregation of amyloid...
Magnetic nanoparticles (MNPs) have great potential in biomedical and clinical applications because o...
Les amyloïdoses sont des maladies caractérisées par l’agrégation structurée de protéines, sous forme...
This review is intended to reflect the recent progress on therapeutic applications of nanomaterials ...
Amyloidosis are diseases characterised by self-agregation of misfolded proteins in fibrillary forms,...
Alzheimers disease (AD) is a common neurodegenerative disease that brings about enormous economic pr...
International audienceMagnetic nanoparticles (MNPs) have great potential in biomedical and clinical ...
Amyloid is defined as insoluble, extracellular, proteinous aggregates formed by misfolding of protei...
International audienceGadolinium-based nanoparticles were functionalized with either the Pittsburgh ...
International audienceAmyloid-β (Aβ) fibrillization is described as a central event in the pathogene...
Alzheimer’s disease (AD) is the most common neurodegenerative disease characterised by the developme...
One of the pathological hallmarks of Alzheimer’s disease (AD) is the abnormal aggregation of amyloid...
Magnetic nanoparticles (MNPs) have great potential in biomedical and clinical applications because o...
Les amyloïdoses sont des maladies caractérisées par l’agrégation structurée de protéines, sous forme...
This review is intended to reflect the recent progress on therapeutic applications of nanomaterials ...
Amyloidosis are diseases characterised by self-agregation of misfolded proteins in fibrillary forms,...
Alzheimers disease (AD) is a common neurodegenerative disease that brings about enormous economic pr...
International audienceMagnetic nanoparticles (MNPs) have great potential in biomedical and clinical ...